Christophe Hennequin

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Hôpital Saint-Louis(Current)

Laboratoire National Henri Becquerel

UniCancer Group

Institut de Recherche en Cancérologie de Montpellier

Institut de Cancérologie de Lorraine

Christophe Hennequin is an author at Hôpital Saint-Louis specializing in prostate disease, genitourinary radiation oncology, and adjuvant androgen deprivation therapy.

Publications per year

2016–2024

Publications

Long-term results of dose escalation (80 vs 70 Gy) combined with long-term androgen deprivation in high-risk prostate cancers: GETUG-AFU 18 randomized trial.

Christophe Hennequin, Paul Sargos, Lise Roca et al. · Journal of Clinical Oncology · 2024 · 37 citations

Medicine, Oncology, Radiation Oncology +17

Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).

Bernard Dubray, Julia Salleron, S. Guérif et al. · Journal of Clinical Oncology · 2016 · 31 citations

Medicine, Oncology, Radiation Oncology +17

<i>Aspergillus</i>antibody detection: diagnostic strategy and technical considerations from the Société Française de Mycologie Médicale (French Society for Medical Mycology) expert committee

Florence Persat, Christophe Hennequin, Jean‐Pierre Gangneux · Medical Mycology · 2016 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

Sylvie Giacchetti, Lilith Faucheux, Charlotte Gardair et al. · Cancers · 2022 · 10 citations · Full text

Medicine, Oncology, Breast Oncology +16

1–4 of 4